AspenBio Pharma Inc http://www.alacrastore.com/company-snapshot/AspenBio_Pharma_Inc-2517550 Wednesday, October 08, 2008 4:54:48 AM 2517550 AspenBio Pharma Inc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0005-28093818newstex/PRN-0005-28093818xml DENVER, Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Smart Move, Inc. (Amex: MVE) announced today the appointment of Jeff McGonegal to serve as a member of the Board of Directors and as Chairman of its Audit Committee....0900000009015000040000000401600004016001040160089/16/2008 11:17:15 AM1800000018007000190000001900100019001006PR Newswire USPRN-0005-28093818ASPENBIO PHARMA INC.CAMBRIDGE HOLDINGS LTDMOVE, INCSMART MOVE INC.CHRIS SAPYTADOUGLAS H KELSALLJEFFREY MCGONEGALAPPYCDGDMOVEMVENewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-26513317newstex/MW-0001-26513317xml CASTLE ROCK, CO, Jul. #, #### (Marketwire delivered by Newstex) -- CASTLE ROCK, CO -- (MARKET WIRE) -- ##/##/## -- AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs...09000000090150000700000007010000040000000400600004006005040060060400200004002006040160000401600807011000070110037/8/2008 12:20:04 PM1800000018007000MarketwireMW-0001-26513317ASPENBIO PHARMA INC.GREGORY PUSEYAPPYNewsNewstexUS - In April ####, the board of AspenBio Pharma Inc, a bio-pharmaceutical company, authorized the repurchase of up to $# mil of the company's common stock outstanding in open market transactions or privately negotiated transactions.4/30/2008 5:15:33 PM045346045346045346045346AspenBio Pharma IncAspenBio Pharma IncAspenBio Pharma IncAspenBio Pharma Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/AspenBio_Pharma_Inc_buys_back_stock-1973352020sdc/19733520201973352020Copyright © 2008, Thomson Financial, All Rights ReservedOTCDrugsUnited StatesPharmaceutical preparations2834COColoradoPublicAPNB2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substancesOTCDrugsUnited StatesPharmaceutical preparations2834COColoradoPublicAPNB762392002Bio-pharm coBio-pharm coCashCash OnlyCommon Stock762392002Apr 30 20080.8590025.86300-6.14700-6.14700-2.77500-1.65200-1.099000.0000026.504000.163000.13800-6.44600-0.24000-6.20100-6.201000.849000.6940031.662000.000000.000000.000000.000000.000000.0000031 Dec 0731 Dec 0731 Dec 0631 Dec 0531 Dec 0431 Dec 031.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000AspenBio Pharma Inc,headquartered in Castle Rock,Colorado, is abio-pharmaceutical companydedicated to the discovery,development, manufacture, andmarketing of novel proprietaryproducts, including those thatenhance the reproductiveefficiency of animals and thathave large worldwide marketpotential. The company wasfounded in August 2000.AspenBio Pharma Inc, headquartered in Castle Rock, Colorado,is a bio-pharmaceutical company dedicated to the discovery,development, manufacture, and marketing of novel proprietaryproducts, including those that enhance the reproductiveefficiency of animals and that have large worldwide marketpotential. The company was founded in August 2000.AspenBio Pharma Inc, headquartered in Castle Rock, Colorado, is a bio-pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of novel proprietary products, including those that enhance the reproductive efficiency of animals and that have large worldwide market potential. The company was founded in August 2000.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000AspenBio Pharma Inc,headquartered in Castle Rock,Colorado, is abio-pharmaceutical companydedicated to the discovery,development, manufacture, andmarketing of novel proprietaryproducts, including those thatenhance the reproductiveefficiency of animals and thathave large worldwide marketpotential. The company wasfounded in August 2000.AspenBio Pharma Inc, headquartered in Castle Rock, Colorado,is a bio-pharmaceutical company dedicated to the discovery,development, manufacture, and marketing of novel proprietaryproducts, including those that enhance the reproductiveefficiency of animals and that have large worldwide marketpotential. The company was founded in August 2000.AspenBio Pharma Inc, headquartered in Castle Rock, Colorado, is a bio-pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of novel proprietary products, including those that enhance the reproductive efficiency of animals and that have large worldwide market potential. The company was founded in August 2000.0.000000.000000.0000031.31000NU.S. Dollar25 Apr 08Fri, 25 Apr 2008 00:00:00 ESTDate Announced: 04/25/2008Date Effective:BuybackNot Appl.0.000000.000000.000000.000000.000000.00000Price/Share0.000005 U.S. Dollar5.000000.000005 U.S. Dollar5.000000.000000.000000.000000.000000.000005 U.S. Dollar1.00000N2.518000.000000.000000.000000.000000.000005.000005.000000.000000.000000.000000.000000.000006.997000.000000.000000.000000.000000.000000.000000.00000-1.234000.000000.000000.000004.079004.870006.010000.000000.000000.098000.000000.000000.000002.95300188.1910026.50400230.734000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000US - In April 2008, the boardof AspenBio Pharma Inc, abio-pharmaceutical company,authorized the repurchase ofup to $5 mil of the company'scommon stock outstanding inopen market transactions orprivately negotiatedtransactions.US - In April 2008, the board of AspenBio Pharma Inc, a bio-pharmaceutical company, authorized the repurchase of up to $5 mil of the company's common stock outstanding in open market transactions or privately negotiated transactions.US - In April 2008, the board of AspenBio Pharma Inc, a bio-pharmaceutical company,authorized the repurchase of up to $5 mil of the company's common stock outstanding inopen market transactions or privately negotiated transactions.US - In April 2008, the board of AspenBio Pharma Inc, a bio-pharmaceutical company, authorized the repurchase of up to $5 mil of the company's common stock outstanding in open market transactions orprivately negotiated transactions.US - In April 2008, the board of AspenBio Pharma Inc, a bio-pharmaceutical company, authorized the repurchase of up to $5 mil of thecompany's common stock outstanding in open market transactions or privately negotiated transactions.Intended0.000000.000000.000000.000000.85900-6.14700-6.14700-2.77500-1.65200-1.099000.0000026.50400-6.44600-0.24000-0.18000-0.15000-0.190000.00000-0.2400026.5040026.504004.425002.423000.959000.00000-6.20100-3.10900-2.11400-2.092000.00000-6.20100-6.20100-3.10900-2.11400-2.092000.00000-6.201000.849001.140000.000000.804000.000000.8490031.6620031.662008.748007.088005.411000.00000Status:IntendedUS-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.0000026.50400111.352000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances762392002OTCUnited States2834ColoradoPublicAPNB2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances762392002OTCUnited States2834ColoradoPublicAPNB5.000005.000005.000002.51800Deal InformationTF Mergers & Acquisitions